ANXV is under clinical development by Annexin Pharmaceuticals and currently in Phase II for Retinal Vein Occlusion.

A multinational study led by the LHON Study Group has revealed sustained visual improvements and a favorable safety profile ...

Nerinetide is under clinical development by NoNO and currently in Phase III for Acute Ischemic Stroke. According to GlobalData, Phase III drugs for Acute Ischemic Stroke have a 13% phase transition ...

The New Year is just around the corner, which means after-Christmas sales are already in full swing. It's not every day you ...

Kodiak Sciences Inc. (NASDAQ:KOD – Get Free Report)’s stock price fell 7.5% during mid-day trading on Friday . The company ...

Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and ...

You'll find my definitive list of the 36 best deals in the Boxing Day sales below, including laptops, TVs, headphones, and ...

The drug and biotech sector had a turbulent year in 2024, starting strong but losing momentum in the second half. This ...

Blood and Shadow slot demo Latest research: Scientists hope to use retinal pigment epithelial stem cells to treat ... 7 COVID-19 vaccines have entered Phase III clinical trials and 4 have been ...

Abnormalities of the vitreoretinal interface may contribute to important retinal pathologies such as diabetic retinopathy, diabetic macular edema and age-related macular degeneration. The ...

This study presents important analyses of the impacts of microexon deletions and loss-of-function in microexon regulators on zebrafish neurite outgrowth and gene expression, as well as adult and ...

King Charles III used his annual Christmas message Wednesday to hail the selflessness of those who have cared for him and the Princess of Wales this year, after both were diagnosed with cancer.